Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

The association between pulmonary hypertension and stroke: a systematic review and meta-analysis.

Shah TG, Sutaria JM, Vyas MV.

Int J Cardiol. 2020 Mar 15;303:78. doi: 10.1016/j.ijcard.2019.12.020. Epub 2019 Dec 12. No abstract available.

PMID:
31864793
2.

DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.

Vyas M, Hechtman JF, Zhang Y, Benayed R, Yavas A, Askan G, Shia J, Klimstra DS, Basturk O.

Mod Pathol. 2019 Nov 1. doi: 10.1038/s41379-019-0398-2. [Epub ahead of print]

PMID:
31676785
3.

Temporal Trends in the Unmet Health Care Needs of Canadian Stroke Survivors.

Vyas MV, Fang J, Kapral MK.

Can J Neurol Sci. 2019 Oct 29:1-7. doi: 10.1017/cjn.2019.319. [Epub ahead of print]

PMID:
31659950
4.

Current Pharmaceutical Interventions and Drug Design in the Management of Diabetes and Diabetic Complications.

Khatik GL, Datusalia AK, Vyas M.

Curr Pharm Des. 2019;25(23):2509. doi: 10.2174/138161282523190913113841.

PMID:
31589109
5.

The Association between Stroke, Integrated Stroke Systems, and the Employability and Productivity of Canadian Stroke Survivors.

Vyas MV, de Oliveira C, Laporte A, Kapral MK.

Neuroepidemiology. 2019;53(3-4):209-219. doi: 10.1159/000502010. Epub 2019 Sep 17.

PMID:
31527374
6.

Adverse Histologic Features in Colorectal Nonpedunculated Malignant Polyps With Nodal Metastasis.

Patel N, Vyas M, Celli R, Jain D, Zhang X.

Am J Surg Pathol. 2020 Feb;44(2):241-246. doi: 10.1097/PAS.0000000000001369.

PMID:
31498179
7.

Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?

Eniu A, Cherny NI, Bertram M, Thongprasert S, Douillard JY, Bricalli G, Vyas M, Trapani D.

ESMO Open. 2019 Jul 17;4(4):e000483. doi: 10.1136/esmoopen-2018-000483. eCollection 2019. Review.

8.

The association between pulmonary hypertension and stroke: A systematic review and meta-analysis.

Shah TG, Sutaria JM, Vyas MV.

Int J Cardiol. 2019 Nov 15;295:21-24. doi: 10.1016/j.ijcard.2019.07.085. Epub 2019 Jul 31.

PMID:
31402157
9.
10.

Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update.

Usman B, Sharma N, Satija S, Mehta M, Vyas M, Khatik GL, Khurana N, Hansbro PM, Williams K, Dua K.

Curr Pharm Des. 2019;25(23):2510-2525. doi: 10.2174/1381612825666190717104547.

PMID:
31333110
11.

An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus.

Bashary R, Vyas M, Nayak SK, Suttee A, Verma S, Narang R, Khatik GL.

Curr Diabetes Rev. 2020;16(2):117-136. doi: 10.2174/1573399815666190618093315. Review.

PMID:
31237215
12.

Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma.

Vyas M, Patel N, Celli R, Wajapeyee N, Jain D, Zhang X.

Gastroenterology Res. 2019 Jun;12(3):128-134. doi: 10.14740/gr1145. Epub 2019 Jun 7.

13.

Smartphone EEG and remote online interpretation for children with epilepsy in the Republic of Guinea: Quality, characteristics, and practice implications.

Williams JA, Cisse FA, Schaekermann M, Sakadi F, Tassiou NR, Hotan GC, Bah AK, Hamani ABD, Lim A, Leung ECW, Fantaneanu TA, Milligan TA, Khatri V, Hoch DB, Vyas MV, Lam AD, Cohen JM, Vogel AC, Law E, Mateen FJ; Guinea Epilepsy Project.

Seizure. 2019 Oct;71:93-99. doi: 10.1016/j.seizure.2019.05.025. Epub 2019 May 31.

PMID:
31229939
14.

Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade.

Wang T, Lee LH, Vyas M, Zhang L, Ganesh K, Firat C, Segal NH, Desai A, Hechtman JF, Ntiamoah P, Weiser MR, Markowitz AJ, Vakiani E, Klimstra DS, Stadler ZK, Shia J.

Mod Pathol. 2019 Oct;32(10):1551-1562. doi: 10.1038/s41379-019-0289-6. Epub 2019 Jun 7.

15.

Shortages of inexpensive essential medicines.

Vyas M, de Vries EGE, Casali PG, Tabernero J.

Lancet Oncol. 2019 May;20(5):e224-e225. doi: 10.1016/S1470-2045(19)30248-7. Epub 2019 Apr 18. No abstract available.

PMID:
31006527
16.

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology.

Giuliani R, Tabernero J, Cardoso F, McGregor KH, Vyas M, de Vries EGE.

ESMO Open. 2019 Mar 6;4(2):e000460. doi: 10.1136/esmoopen-2018-000460. eCollection 2019.

17.

Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases.

Mehta M, Deeksha, Sharma N, Vyas M, Khurana N, Maurya PK, Singh H, Andreoli de Jesus TP, Dureja H, Chellappan DK, Gupta G, Wadhwa R, Collet T, Hansbro PM, Dua K, Satija S.

Chem Biol Interact. 2019 May 1;304:10-19. doi: 10.1016/j.cbi.2019.02.021. Epub 2019 Mar 5. Review.

PMID:
30849336
18.

Hypolipidemic effect of Rukshana Upakrama in the management of dyslipidemia - A case study.

Patel B, Kamble SB, Vyas HA, Vyas MK, Chinthala R.

Ayu. 2018 Apr-Jun;39(2):72-75. doi: 10.4103/ayu.AYU_88_17.

19.

Acquired resistance to immunotherapy in MMR-D pancreatic cancer.

Hu ZI, Hellmann MD, Wolchok JD, Vyas M, Shia J, Stadler ZK, Diaz LA Jr, O'Reilly EM.

J Immunother Cancer. 2018 Nov 20;6(1):127. doi: 10.1186/s40425-018-0448-1.

20.

Atypical Clinical Presentation and Imaging Findings of Central Nervous System Tuberculosis.

Vyas MV, Bunce PE, Kiehl TR, Bernstein M, Wennberg R.

Can J Neurol Sci. 2018 Nov;45(6):686-687. doi: 10.1017/cjn.2018.356. No abstract available.

PMID:
30430973
21.

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Kloess S, Ede Valverde da Silva A, Oberschmidt O, Gardlowski T, Matthies N, Vyas M, Arseniev L, Heuser M, Pogge von Strandmann E, Köhl U.

Front Immunol. 2018 Oct 8;9:2326. doi: 10.3389/fimmu.2018.02326. eCollection 2018.

22.

Multivariate analysis of short time series in terms of ensembles of correlation matrices.

Vyas M, Guhr T, Seligman TH.

Sci Rep. 2018 Oct 2;8(1):14620. doi: 10.1038/s41598-018-32891-4.

23.

Preparing for the incoming wave of biosimilars in oncology.

Wolff-Holz E, Garcia Burgos J, Giuliani R, Befrits G, de Munter J, Avedano L, Aitken M, Gonzalez-Quevedo R, Vyas M, de Vries EGE, Tabernero J.

ESMO Open. 2018 Sep 5;3(6):e000420. doi: 10.1136/esmoopen-2018-000420. eCollection 2018. Erratum in: ESMO Open. 2018 Oct 14;3(6):e000420corr1.

24.

Representation of ethnic groups in dementia trials: systematic review and meta-analysis.

Vyas MV, Raval PK, Watt JA, Tang-Wai DF.

J Neurol Sci. 2018 Nov 15;394:107-111. doi: 10.1016/j.jns.2018.09.012. Epub 2018 Sep 12.

PMID:
30243103
25.

Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas.

Liu S, Gӧnen M, Stadler ZK, Weiser MR, Hechtman JF, Vakiani E, Wang T, Vyas M, Joneja U, Al-Bayati M, Segal NH, Smith JJ, King S, Guercio S, Ntiamoah P, Markowitz AJ, Zhang L, Cercek A, Garcia-Aguilar J, Saltz LB, Diaz LA, Klimstra DS, Shia J.

Mod Pathol. 2019 Jan;32(1):110-121. doi: 10.1038/s41379-018-0114-7. Epub 2018 Aug 30.

26.

Utilization of Vasculoprotective Therapy for Peripheral Artery Disease: A Systematic Review and Meta-analysis.

Hackam DG, Vyas MV.

Am J Med. 2018 Nov;131(11):1332-1339.e3. doi: 10.1016/j.amjmed.2018.07.006. Epub 2018 Jul 26.

PMID:
30056102
27.

Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus.

Kaur P, Mittal A, Nayak SK, Vyas M, Mishra V, Khatik GL.

Curr Drug Targets. 2018;19(15):1738-1766. doi: 10.2174/1389450119666180727142902. Review.

PMID:
30051787
28.

Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation.

Janostiak R, Vyas M, Cicek AF, Wajapeyee N, Harigopal M.

Exp Mol Pathol. 2018 Aug;105(1):41-49. doi: 10.1016/j.yexmp.2018.05.011. Epub 2018 May 28.

PMID:
29852185
29.

A practical diagnostic approach to hepatic masses.

Vyas M, Jain D.

Indian J Pathol Microbiol. 2018 Jan-Mar;61(1):2-17. doi: 10.4103/IJPM.IJPM_578_17. Review.

30.

Global cancer control: responding to the growing burden, rising costs and inequalities in access.

Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, Sonke GS, Martínez GA, Frenel JS, Karamouzis M, Strijbos M, Yazici O, Bossi P, Banerjee S, Troiani T, Eniu A, Ciardiello F, Tabernero J, Zielinski CC, Casali PG, Cardoso F, Douillard JY, Jezdic S, McGregor K, Bricalli G, Vyas M, Ilbawi A.

ESMO Open. 2018 Feb 2;3(2):e000285. doi: 10.1136/esmoopen-2017-000285. eCollection 2018.

31.

Battery of Behavioral Tests Assessing General Locomotion, Muscular Strength, and Coordination in Mice.

Osmon KJ, Vyas M, Woodley E, Thompson P, Walia JS.

J Vis Exp. 2018 Jan 23;(131). doi: 10.3791/55491.

32.

The use of cannabis in response to the opioid crisis: A review of the literature.

Vyas MB, LeBaron VT, Gilson AM.

Nurs Outlook. 2018 Jan - Feb;66(1):56-65. doi: 10.1016/j.outlook.2017.08.012. Epub 2017 Sep 21. Review.

PMID:
28993073
33.

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Kloess S, Ede Valverde da Silva A, Oberschmidt O, Gardlowski T, Matthies N, Vyas M, Arseniev L, Heuser M, Pogge von Strandmann E, Köhl U.

Front Immunol. 2017 Sep 8;8:1100. doi: 10.3389/fimmu.2017.01100. eCollection 2017. Erratum in: Front Immunol. 2018 Oct 08;9:2326.

34.

Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.

Vyas M, Reinartz S, Hoffmann N, Reiners KS, Lieber S, Jansen JM, Wagner U, Müller R, von Strandmann EP.

Oncoimmunology. 2017 Aug 21;6(9):e1339854. doi: 10.1080/2162402X.2017.1339854. eCollection 2017.

35.

A Retrospect Study on Thiazole Derivatives as the Potential Antidiabetic Agents in Drug Discovery and Developments.

Khatik GL, Datusalia AK, Ahsan W, Kaur P, Vyas M, Mittal A, Nayak SK.

Curr Drug Discov Technol. 2018;15(3):163-177. doi: 10.2174/1570163814666170915134018. Review.

PMID:
28914188
36.

Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers.

Tabernero J, Vyas M, Giuliani R, Arnold D, Cardoso F, Casali PG, Cervantes A, Eggermont AM, Eniu A, Jassem J, Pentheroudakis G, Peters S, Rauh S, Zielinski CC, Stahel RA, Voest E, Douillard JY, McGregor K, Ciardiello F.

ESMO Open. 2017 Jan 16;1(6):e000142. doi: 10.1136/esmoopen-2016-000142. eCollection 2016. Review.

37.

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) in a young female athlete at 36 weeks gestation: a case report.

Choung HYG, Vyas M, Jacoby D, West B.

Pathol Res Pract. 2017 Oct;213(10):1302-1305. doi: 10.1016/j.prp.2017.07.015. Epub 2017 Jul 25.

PMID:
28843747
38.

Incidence and management of seizures after ischemic stroke: Systematic review and meta-analysis.

Wang JZ, Vyas MV, Saposnik G, Burneo JG.

Neurology. 2017 Sep 19;89(12):1220-1228. doi: 10.1212/WNL.0000000000004407. Epub 2017 Aug 23. Review.

PMID:
28835405
39.

Effect of Crown Angulation of Maxillary Incisor on Effective Arch Perimeter.

Jain M, Vyas M, Singh JR.

J Clin Diagn Res. 2017 Jun;11(6):ZC92-ZC96. doi: 10.7860/JCDR/2017/24222.10139. Epub 2017 Jun 1.

40.

Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.

Bobylev I, Peters D, Vyas M, Barham M, Klein I, von Strandmann EP, Neiss WF, Lehmann HC.

Neurotox Res. 2017 Nov;32(4):555-562. doi: 10.1007/s12640-017-9760-7. Epub 2017 Jun 13.

PMID:
28612296
41.

Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.

Karimi S, Vyas MV, Gonen L, Tabasinejad R, Ostrom QT, Barnholtz-Sloan J, Suppiah S, Zadeh G, Aldape K.

Neuro Oncol. 2017 Oct 19;19(11):1503-1510. doi: 10.1093/neuonc/nox089.

42.

Antigen Loss Variants: Catching Hold of Escaping Foes.

Vyas M, Müller R, Pogge von Strandmann E.

Front Immunol. 2017 Feb 24;8:175. doi: 10.3389/fimmu.2017.00175. eCollection 2017.

43.

Outcomes associated with prescribed medications in older adults with multimorbidity: protocol for a scoping review.

Watt J, Tricco AC, Vyas M, Kohli K, Soin S, Abaeian M, Watt S, Straus SE.

BMJ Open. 2017 Feb 23;7(2):e014529. doi: 10.1136/bmjopen-2016-014529. Review.

44.

Knock down of Whitefly Gut Gene Expression and Mortality by Orally Delivered Gut Gene-Specific dsRNAs.

Vyas M, Raza A, Ali MY, Ashraf MA, Mansoor S, Shahid AA, Brown JK.

PLoS One. 2017 Jan 3;12(1):e0168921. doi: 10.1371/journal.pone.0168921. eCollection 2017.

45.
46.

Lost Productivity in Stroke Survivors: An Econometrics Analysis.

Vyas MV, Hackam DG, Silver FL, Laporte A, Kapral MK.

Neuroepidemiology. 2016;47(3-4):164-170. doi: 10.1159/000454730. Epub 2016 Dec 20.

PMID:
27992866
47.

Publisher's Note: Generalized Gaussian wave packet dynamics: Integrable and chaotic systems [Phys. Rev. E 93, 012213 (2016)].

Pal H, Vyas M, Tomsovic S.

Phys Rev E. 2016 Nov;94(5-2):059904. Epub 2016 Nov 7.

PMID:
27967126
48.

Intestinal metaplasia of appendiceal endometriosis is not uncommon and may mimic appendiceal mucinous neoplasm.

Vyas M, Wong S, Zhang X.

Pathol Res Pract. 2017 Jan;213(1):39-44. doi: 10.1016/j.prp.2016.10.011. Epub 2016 Oct 25.

PMID:
27913053
49.

Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.

Vyas M, Schneider AC, Shatnyeva O, Reiners KS, Tawadros S, Kloess S, Köhl U, Hallek M, Hansen HP, Pogge von Strandmann E.

Oncoimmunology. 2016 Jul 15;5(9):e1211220. eCollection 2016.

50.

Metastatic tumors in the jaw bones: A retrospective clinicopathological study of 12 cases at Tertiary Cancer Center.

Nawale KK, Vyas M, Kane S, Patil A.

J Oral Maxillofac Pathol. 2016 May-Aug;20(2):252-5. doi: 10.4103/0973-029X.185920.

Supplemental Content

Support Center